The tennis legend caused a stir earlier in the week after complaining over a cotton plant - which was used as a decoration - ...

Purdue switched its pharmacy benefit manager from CVS Caremark to AffirmedRx, citing more transparency for drug costs.

Excellus BlueCross BlueShield is pushing back against reports that it will no longer cover GLP-1 medications, saying drugs ...

President Donald Trump unveiled a slew of new tariffs, including 100% levies on pharmaceuticals imports, but exempted drug ...

Fractyl Health (GUTS) announced on Friday that patients who stopped taking the GLP-1 class drug Tirzepatide and were treated ...

Though the trial for patients with obesity and type 2 diabetes will come to an end, an obesity-only trial will continue.

AstraZeneca said on Friday it will sell its diabetes and asthma drugs direct to cash-paying U.S. patients at a discount of up ...

Novo Nordisk's Q2 2025 sales surge as Wegovy demand grows, driven by new obesity drug data. Click here to read an analysis of ...

Viking Therapeutics targets obesity and MASH with high-risk prospects, trial concerns, and strong funding, but lags leaders ...

The researchers found that, compared to the AGHE, the Mediterranean diet resulted in a significant decrease in waist ...

PGIM, an investment management company, released its “PGIM Jennison Health Sciences Fund” second-quarter 2025 investor letter ...

The decision to stop the Phase IIb study was driven by “strategic business reasons,” according to a federal clinical trials ...